Digital Pathology Market worth $437 Million by 2018, According to a New Study on ASDReports

Wednesday 17 September 2014, Amsterdam

The new report, now available on ASDReports, "Digital Pathology Market Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & Whole Slide Image Storage - Global Forecasts & Trends to 2018" analyzes and studies the major market drivers and restraints in geographies such as North America, Europe, Asia, and the Rest of the World (RoW).

This report studies the global digital pathology market over the forecast period of 2013 to 2018. The market was estimated at $250.2 million in 2013 and is expected to reach $437 million by 2018, growing at a CAGR of 11.8% from 2013 to 2018.

This report covers the definition, description, and forecast of the digital pathology market in terms of products and applications. Based on products, the digital pathology market comprises of scanners, analytics, storage, and communication.

The application market is categorized into human and animal pathology. Human pathology is segmented into pharmaceutical and biotech companies, hospitals and reference laboratories, and training and education centers, while animal pathology is segmented into pharmaceutical and biotechnology companies, contract research organizations, and academic and government research institutes.

North America accounted for the largest share of the global digital pathology market, followed by Europe and Asia. The dominance of the North American market can be attributed to the favorable reimbursement scenario in the U.S. and the use of digital pathology to improve the quality of cancer diagnosis in Canada. However, the Asian market is expected to experience the highest growth in the digital pathology market. The high growth in this region can be attributed to the rise in awareness of digital pathology and its benefits, collaborative efforts by players, and federal health departments encouraging the use of digital pathology to improve the quality of cancer diagnosis.

Some of the prominent players in the global digital pathology market include 3DHistech (Hungary), Leica Biosystems (Germany), Ventana Medical Systems (U.S.), Hamamatsu Photonics K.K. (Japan), Mikroscan Technologies (U.S.), Definiens AG (Germany), Visiopharm (Denmark), and Indica Labs (U.S.).